A congressional committee heard complaints Tuesday against the owners of Purdue Pharma, the developer of OxyContin, as it mulled longshot legislation that would prevent them from using company bankruptcy as a shield from personal culpability.
Rep. Carolyn Maloney called a hearing with two general prosecutors, opioid militants, and the author to set the case against the Sackler family members of Connecticut’s pharmaceutical juggernaut, whose criminal prosecution of the commercialization of OxyContin has been twice pled guilty.The victims of the Opiate Supply are on the path of justice, and the Republican prosecutor, Lawrence Wasden, stated to their families.
Around 3,000 lawsuits from state and municipal governments all over America were reported.Debtors are protected against litigation as part of the bankruptcy procedure. Some bankruptcy courts are also ready to protect non-debtors, notably the one in the White Plains in New York, where Purdue sought protection.Maloney’s measure, known as the SACKLER Act, would restrict non-debtor protection. The statute may subject families to lawsuits brought by more than 20 other lawyers, who aim to make them individually responsible for the opioid epidemic.